Odaka Mizuho, Minakata Kenji, Toyokuni Hideaki, Yamazaki Kazuhiro, Yonezawa Atsushi, Sakata Ryuzo, Matsubara Kazuo
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Kyoto, 606-8507, Japan,
Gen Thorac Cardiovasc Surg. 2015 Aug;63(8):446-52. doi: 10.1007/s11748-015-0552-9. Epub 2015 Apr 30.
This study aimed to develop and assess the effectiveness of a protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery.
We established a protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery. This novel protocol was assessed by comparing patients undergoing open heart surgery before (control group; n = 30) and after its implementation (protocol group; n = 31) at Kyoto University Hospital between July 2012 and January 2013.
Surgical site infections (SSIs) were observed in 4 control group patients (13.3 %), whereas no SSIs were observed in the protocol group patients (P < 0.05). The total duration of antibiotic use decreased significantly from 80.7 ± 17.6 h (mean ± SD) in the control group to 55.5 ± 14.9 h in the protocol group (P < 0.05). Similarly, introduction of the protocol significantly decreased the total antibiotic dose used in the perioperative period (P < 0.05). Furthermore, antibiotic regimens were changed under suspicion of infection in 5 of 30 control group patients, whereas none of the protocol group patients required this additional change in the antibiotic regimen (P < 0.05).
Our novel antibiotic prophylaxis protocol based on preoperative kidney function effectively prevents SSIs in patients undergoing open heart surgery.
本研究旨在制定并评估一项基于术前肾功能的心脏直视手术患者抗生素预防方案的有效性。
我们为心脏直视手术患者制定了一项基于术前肾功能的抗生素预防方案。2012年7月至2013年1月期间,在京都大学医院,通过比较该方案实施前(对照组;n = 30)和实施后(方案组;n = 31)接受心脏直视手术的患者,对这一新型方案进行了评估。
对照组有4例患者(13.3%)发生手术部位感染(SSIs),而方案组患者未观察到SSIs(P < 0.05)。抗生素使用的总时长从对照组的80.7 ± 17.6小时(均值 ± 标准差)显著降至方案组的55.5 ± 14.9小时(P < 0.05)。同样,该方案的引入显著降低了围手术期使用的抗生素总剂量(P < 0.05)。此外,对照组30例患者中有5例因怀疑感染而更改了抗生素治疗方案,而方案组患者均无需进行这种额外的抗生素治疗方案更改(P < 0.05)。
我们基于术前肾功能的新型抗生素预防方案能有效预防心脏直视手术患者发生SSIs。